BSPM — Biostar Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Biostar Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2012 December 31st	2013 December 31st	2014 December 31st	2015 December 31st	2016 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-20	0.809	4.85	-25.1	-5.7
Depreciation
Deferred Taxes
Non-Cash Items	10.3	2.1	6.31	21.6	-0.265
Unusual Items
Other Non-Cash Items
Changes in Working Capital	6.3	2.24	-6.65	5.76	7.08
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-3.58	8.91	3.31	5.88	4.91
Capital Expenditures	-8.75	-0.982	-2.87	-0.059	0
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-8.54	-3.23	-6.01	-7.32	-6.38
Acquisition of Business
Sale of Fixed Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-17.3	-4.21	-8.88	-7.38	-6.38
Financing Cash Flow Items	1.58	-1.61	0	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	5.55	-6.46	6.95	-0.161	1.41
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-15.2	-1.68	1.61	-1.65	0.134